用先前的疫苗接种来开发新的疫苗
H M Etlinger1, D Gillessen, H W Lahm
1Central Research Unit F. Hoffmann-La Roche, Basel, Switzerland.
概括
开发新疫苗需要增强免疫原性. 一种来自毒素的新型载体成功地促进了对链接表位体的抗体反应,而不会导致抑制,提供了新的疫苗开发策略.
科学领域:
- 疫苗学 疫苗学 疫苗学
- 免疫学 免疫学 免疫学
- 蛋白质化学 蛋白质化学
背景情况:
- 提高疫苗免疫性是至关重要的,因为保护性表位通常免疫性很差.
- 目前用于增强表位细胞免疫原性的载体策略存在局限性,可能是由于先前接种疫苗的表位细胞特异性抑制.
- 位特异性抑制可以抑制抗体对与先前遇到的蛋白质相关的新位的反应.
研究的目的:
- 为了识别一种增强链接B细胞表位体免疫原性的载体,而不会诱导抑制.
- 通过利用先前的疫苗接种,开发一种改善疫苗设计的一般方法.
主要方法:
- 来自毒素的特定的鉴定,具有载体功能但不具有抑制作用.
- 将已识别的与模型B细胞表位连接起来.
- 在疹毒素原料动物模型中对链接结构的体内测试.
主要成果:
- 新型载体增强了对链接的B细胞表位体的抗体反应.
- 携带者没有诱导先前接种疫苗的接受者表位特异性抑制.
- 这种方法成功地绕过了先前毒素疫苗接种中介的抑制.
结论:
- 来自毒素的可以作为一种有效的载体来增强链接表位体的免疫性.
- 这种策略克服了表位特异性抑制,为新疫苗开发提供了有希望的方法.
- 通过这种方法利用以前的疫苗接种可能是设计更有效疫苗的总体策略.
相关概念视频
Vaccinations
Overview
Cancer Vaccines
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Microorganisms in Medicine and Therapeutics
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
Vaccine Production
Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...
Vaccines
Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...
Smallpox
Smallpox is a severe contagious disease caused by the Variola major virus, a double-stranded DNA member of the Poxviridae family.Variola major transmission occurs primarily via inhalation of virus-laden droplets or direct contact with infectious scabs. The incubation period averages approximately seven days, although it may range from 7 to 17 days depending on the inoculum and host factors.Clinically, the prodromal phase is marked by an abrupt onset of high fever, malaise, headache, and myalgia.


